Skip to main content
Figure 2 | Molecular Cancer

Figure 2

From: Targeting DNA-PKcs and telomerase in brain tumour cells

Figure 2

MST-312 induces telomere shortening and reduces cell proliferation in brain tumour cells. (A) Total genomic DNA prepared from MO59K, KNS60 and ONS76 cells treated with 0.5 μM MST-312 for indicated number of days was assessed for telomere length using TRF assay. (B-D) Cell proliferation capacity in 0.5 μM MST-312 treated brain tumour cells were analysed with trypan blue exclusion assay.

Back to article page